Medicare AdvantageDocumentationMedium impact
MA08.017n, Botulinum Toxin Agents
Independence Blue Cross·Dermatology, Neurology, Plastic Surgery +1 more·Medical Policy
Effective date
Jun 29, 2026
We identified it
Jun 30, 2026
Summary
Medicare Advantage policy MA08.017n for Botulinum Toxin Agents has been updated with changes to medical necessity criteria and/or medical coding requirements. The policy is effective immediately (06/29/2026) and requires billing team review to ensure compliant claim submission and coding practices.
Action Required
By 06/29/2026: Billing team must access the full policy text at https://medpolicy.ibx.com/ibc/ma/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=06&FilterField2=MPSiteActivityLogYear&FilterValue2=2026#medicare-advantage-ma08-017n-botulinum-toxin-agents to identify specific CPT/HCPCS codes, medical necessity criteria, and coding requirements for botulinum toxin agents. Update billing software, encounter forms, and prior authorization workflows accordingly. Ensure providers document medical necessity per new criteria. Implement changes before claim submission to avoid denials.